Table of Contents
Our editorial workforce is celebrating the closing week of the year by recapping some of our most popular stories and content from the previous calendar year. Listed here, we are highlighting our most well known information associated to diabetes technological innovation from 2022. Of notice, this record does not include things like regulatory information or guideline recommendations as both of these subject areas were protected in their personal yr in assessment recaps.
Review Finds Dexcom G7 Setup is Less complicated, Necessitates Much less Duties for Older Grownups than Prior Generations
New information from a compact examine evaluating ease of uptake of the Dexcom G7 constant glucose checking method is underlining the effect of advancing engineering on accessibility and use of newer CGM systems as section of diabetes administration.
A 10-individual study evaluating uptake of the Dexcom G7 CGM procedure amongst a population of older grown ups with the support of a certified diabetic issues care and instruction professional, benefits show that G7 CGM program demanded 50 % as many methods to established up and deploy as the G6 process, with the system’s method usability scale survey scores indicating superb usability.
Diabetic issues Dialogue: Optimizing CGM Uptake in Principal Treatment
In the very first of 4 exclusive edition episodes from ADA 2022, Diabetes Dialogue hosts Drs. Diana Isaacs and Natalie Bellini just take on the purpose of interviewers and talk about CGM uptake in principal care with Drs. Sean and Tamara Oser. Later in the episode, the pair give perspective on their encounters with Beta Bionics’ Insulin-Only Bionic Pancreas.
iLet Bionic Pancreas Increases Glycemic Control, Time in Goal Assortment in Form 1 Diabetes
Complete information from the 13-7 days demo of the iLet insulin-only bionic pancreas particulars the improvements in glycemic management accomplished with use of the bionic pancreas in adults and young children with type 1 diabetes aged from as young as 6 many years previous and up to 79 several years of age.
With funding from the Countrywide Institute of Diabetic issues and Digestive and Kidney Health conditions, success of the 13-7 days randomized trial advise use of BetaBionics’ iLet bionic pancreas was related with better reductions in HbA1c than normal treatment, with all those using a bionic pancreas encounter a larger proportion of time in variety as nicely.
Increased Scanning Frequency Increases Glucose Handle, Hypoglycemia Panic in T1D Employing CGM
Elevated scanning can lessen panic of hypoglycemia amongst people today with variety 1 diabetes working with intermittently scanned CGM systems, according to the final results of a new review.
An assessment of clinical info and ambulatory glucose profile experiences from an outpatient clinic in Poland, effects of the research show increased frequency of scanning with intermittently scanned CGM products was associated with make improvements to glycemic command and diminished worry of hypoglycemia among the persons with type 1 diabetic issues.
Dexcom Announces International Launch of Dexcom G7 Glucose Checking System
The Dexcom G7 Steady Glucose Monitoring (CGM) System rollout commenced on Oct 4 with the enterprise announcing its availability for persons with diabetes aged 2 a long time and more mature in the United Kingdom, Ireland, Germany, Austria, and Hong Kong, with a rollout in New Zealand and South Africa expected within the next months.